CannabisNewsBreaks

MondayNov 06, 2017 12:03 pm

CannabisNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates

India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing this reads: “IGC’s unique strategy reduces regulatory approval time and development costs because its chosen categories face lower regulatory burdens. Instead of pursuing full novel drug applications, which take anywhere from 7-9 years in clinical trials and cost hundreds of millions before securing FDA approval, IGC is developing cannabis-based drugs that could be commercialized in less than two years and…

Continue Reading

FridayNov 03, 2017 12:16 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool. An article discussing this reads: “InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids (http://cnw.fm/hFe3o). The company recently announced it has enabled the production of all four “gateway” cannabinoids using genetically engineered microorganisms. From these gateway substrates, production of all 90+ cannabinoids is possible via biosynthesis. InMed’s breakthrough stands to make the production of cannabis derivatives, including THC, CBD…

Continue Reading

FridayNov 03, 2017 12:15 pm

CannabisNewsBreaks – Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients. Skinvisible out-licenses its formulations, enabling companies like Canopy Hemp Corporation to bring their own patented products to market and combat generic competitors. An article discussing this reads: “With a $80 billion global dermatology market and a $30 billion global skin care over-the-counter (OTC) market, the patented polymer delivery system for topical products developed by Skinvisible, obviously, has many, many possible applications. The company has already…

Continue Reading

FridayNov 03, 2017 12:14 pm

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Targets Global Cannabis Market

As a licensed producer under the Marijuana for Medical Purposes Regulations in Canada, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) sells cannabis through its ABcann Medicinals, Inc. subsidiary. “We’re now, hopefully, going to be a global presence,” director Aaron Keay said in an interview with CannabisFN (CFN Media). An article discussing this reads: “ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America (http://cnw.fm/3uiqM). The company sells in…

Continue Reading

ThursdayNov 02, 2017 2:19 pm

CannabisNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Enters CBD Market through Strategic Acquisition

Grey Cloak Tech, Inc. (OTCQB: GRCK) recently entered the booming cannabis industry through the strategic acquisition of a medically-focused CBD company, Eqova Life Sciences. An article discussing this reads: “On October 24, 2017, Grey Cloak Tech, Inc. (OTCQB: GRCK) announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products. The company sent a letter of intent pertaining to the acquisition in September. Eqova, a company located in Denver, develops clinical-grade full spectrum hemp oil products, and it distributes via partnerships with licensed medical practitioners.” To view the full article,…

Continue Reading

ThursdayNov 02, 2017 2:19 pm

CannabisNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals, because Hyalolex does not need FDA approval. An article discussing this reads: “This hugely accelerated introduction of Hyalolex can only be accomplished in states where medical cannabis is legal and where the ailment (in this case Alzheimer’s) is an approved medical condition. In states where…

Continue Reading

ThursdayNov 02, 2017 12:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Acquisition of 100% Ownership Interest in Poviva Tea, LLC

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced that it has acquired 100 percent ownership interest in its majority owned subsidiary, Poviva Tea, LLC. Lexaria previously owned 51 percent interest in Poviva Tea. “This acquisition strengthens Lexaria's intellectual property positioning and we reaffirm our commitment to the ViPova Tea product lines,” Chris Bunka, chief executive officer of Lexaria, stated in the news release. “Lexaria thanks the founders of Poviva Tea, LLC for their assistance and vision in this transaction.” Per the update, compensation related…

Continue Reading

ThursdayNov 02, 2017 11:48 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018. “We are thrilled to have completed the sale of PotSaver’s premiere Los Angeles edition,” Vanessa Luna, COO of MTRAC, stated in the news release. “With the new recreational law going into effect at the turn of the new year, we are truly in the most exciting, but also crucial time in this industry’s young history. By…

Continue Reading

ThursdayNov 02, 2017 9:54 am

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Achieves 29% QoQ Revenue Increase in 3Q17

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., reported revenues of nearly $4.5 million for the third quarter of fiscal 2017, realizing a net quarter-over-quarter increase of 29 percent. “We are very pleased with this quarter’s results and forge ahead into the fourth quarter with strengthened anticipation once again,” Dr. Richard Goulding, CEO of PotNetwork, stated in the news release. As recently reported, PotNetwork has retained the auditing services of East West Accounting Services, LLC, a Public Company Accounting Oversight Board (“PCAOB”) registered CPA firm, to provide a methodical review and analysis…

Continue Reading

WednesdayNov 01, 2017 12:22 pm

CannabisNewsBreaks – Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery

Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company also aims to create a safe delivery method of cannabinoids and is currently working toward this goal with two universities in Canada. An article discussing this reads: “In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat…

Continue Reading